ArticleBMC complementary medicine and therapies2025
Cost-effectiveness of Qiliqiangxin in HFrEF: adjunctive therapy vs. standard care from a Chinese healthcare perspective.
Yake Lou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.